Search Results - "Dell'Acqua, Raffaele"
-
1
RISK OF CARDIOVASCULAR DISEASES OR MORTALITY IN PEOPLE WITH HIGHER VALUES OF HIV-1 DNA
Published in Journal of acquired immune deficiency syndromes (1999) (01-06-2023)Get full text
Journal Article -
2
Enhanced Immunological Recovery With Early Start of Antiretroviral Therapy During Acute or Early HIV Infection-Results of Italian Network of ACuTe HIV InfectiON (INACTION) Retrospective Study
Published in Pathogens & immunity (24-02-2020)“…Viral load peak and immune activation occur shortly after exposure during acute or early HIV infection (AEHI). We aimed to define the benefit of early start of…”
Get full text
Journal Article -
3
Long-term successfull management of recurrent episodes of nontuberculous mycobacterial infection in an apparently healthy Chinese woman
Published in Annals of clinical microbiology and antimicrobials (03-08-2024)“…Disseminated non-tuberculous mycobacteria (dNTM) infections are mostly reported among individuals with an underlying congenital or acquired immunodeficiency or…”
Get full text
Journal Article -
4
Exploring the Association between Delirium and Malnutrition in COVID-19 Survivors: A Geriatric Perspective
Published in Nutrients (01-11-2023)“…Older individuals face an elevated risk of developing geriatric syndromes when confronted with acute stressors like COVID-19. We assessed the connection…”
Get full text
Journal Article -
5
Viro-immunological outcomes after 13-valent pneumococcal vaccination in HIV-1-infected individuals on stable virological suppression
Published in AIDS (London) (01-11-2019)“…BACKGROUND:Very limited data are available on the immunovirological outcomes after 13-valent pneumococcal conjugate vaccine (PCV13) in antiretroviral therapy…”
Get full text
Journal Article -
6
HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ?
Published in International journal of infectious diseases (01-09-2017)“…•This study was performed to assess the safety and efficacy of direct-acting antivirals (DAAs) in a real-life setting in both hepatitis C virus (HCV)…”
Get full text
Journal Article -
7
Renal function changes in HCV-infected patients with chronic kidney disease during and after treatment with direct antiviral agents
Published in Digestive and liver disease (01-10-2017)Get full text
Journal Article -
8
Coadministration of isavuconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipients
Published in Therapeutic advances in infectious disease (01-01-2024)“…Background: Invasive fungal infections (IFIs) represent a major cause of morbidity among allogeneic hematopoietic stem cell transplantation (allo-HSCT)…”
Get full text
Journal Article -
9
SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic
Published in The New microbiologica (01-10-2020)“…We describe the outcome of a Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) IgG/IgM rapid test, and discuss the potential suitability of antibody…”
Get full text
Journal Article -
10
An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia
Published in Malaria journal (14-04-2017)“…Imported cases of multidrug resistant Plasmodium falciparum and treatment failure with artemisinin-based regimens, although rare, have been described also in…”
Get full text
Journal Article -
11
The elderly and direct antiviral agents: constraint or challenge?
Published in Digestive and liver disease (01-09-2017)“…Abstract Background direct antiviral agents (DAAs) for chronic hepatitis C showed great effectiveness and good safety profile. So far, few data are available…”
Get full text
Journal Article -
12
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
Published in Clinical microbiology and infection (01-03-2021)“…The aim of our study was to describe the incidence and predictive factors of secondary infections in patients with coronavirus disease 2019 (COVID-19). This…”
Get full text
Journal Article -
13
Retrospective study on the outcome of two-drug regimens based on dolutegravir plus one reverse transcriptase inhibitor in virologically-suppressed HIV-infected patients
Published in International journal of antimicrobial agents (01-03-2020)“…•Dolutegravir-based 2-drugs regimens effective and safe as switch strategy.•Drug-resistance at failure predictable by the failing regimen.•Historical…”
Get full text
Journal Article -
14
P1549: HIGH PREVALENCE OF RESPIRATORY SYNCYTIAL VIRUS IN HAEMATOLOGICAL PATIENTS AFTER COVID19 WAVES
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
15
Safety and effectiveness of a 12-week course of sofosbuvir and simeprevir ± ribavirin in HCV-infected patients with or without HIV infection: a multicentre observational study
Published in International journal of antimicrobial agents (01-03-2017)“…Highlights • To assess safety and effectiveness of sofosbuvir and simeprevir ± ribavirin in HCV- and HIV/HCV-infected patients. • No significant difference…”
Get full text
Journal Article -
16
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19
Published in Open forum infectious diseases (01-09-2022)“…Abstract Background This study’s primary aim was to evaluate the impact of thrombotic complications on the development of secondary infections. The secondary…”
Get full text
Journal Article